Why Cannabis Stocks Dropped 10% on Monday

Cannabis stocks lost around 10% of their gains last week, just as the United States comes to vote on cannabis legalization in the House of Representatives.

| More on:
Cannabis stocks have fallen.

Cannabis stocks lost some of the gains made last week, with a few dropping over 10% on Monday. This included companies like Canopy Growth (TSX:WEED)(NASDAQ:CGC), Aurora Cannabis (TSX:ACB)(NYSE:ACB), and Tilray (TSX:TLRY)(NASDAQ:TLRY).

What happened?

Shares of cannabis stocks jumped nearing the end of last week to heights investors hadn’t seen in months. It came as news that the Marijuana Opportunity Reinvestment and Expungement (MORE) Act would be put before the United States House of Representatives this week.

However, it looks like, over the weekend, many investors took the opportunity to sell some of their shares after the quick gains. After all, as mentioned these gains haven’t been seen in some time. And not only do we still trade in a volatile market, but it, unfortunately, doesn’t seem like the MORE Act will get through the Senate.

So what?

The MORE Act has gone through the U.S. House before. And it passed in that case, which it’s likely to do once more this week. So, that’s good news, right? Well, perhaps, but it’s unlikely to pass through the Republican-controlled Senate. And that’s exactly what happened before.

The point of the move is to bring attention to the need to keep marijuana decriminalization and legalization moving forward. The U.S. continues to miss out on larger opportunities for making a killing on the burgeoning cannabis industry. Therefore, cannabis stocks could remain stagnant or drop until such a time that the U.S. sees legalization through.

Now what?

If you were looking for a time to sell your cannabis stocks, I don’t blame you for getting rid of them over the weekend. But if you’re a long-term investor in the cannabis industry, then there are a few I certainly would continue to hold onto. In fact, you could even up your stake at a time like this.

I would pass on Aurora Cannabis stock for now, as the company continues to make purchases without much proof of its worth. Tilray stock is a strong option, proving it can create enough profit to grow through acquisition. Meanwhile, Canopy Growth stock is in between. It’s not yet profitable but could explode when the U.S. legalizes marijuana.

So, right now, it’s a wait-and-see game. Though cannabis stocks may shoot up once more should the U.S. House pass through the MORE Act this week. And that, at the very least, looks likely.

Shares of Canopy Growth stock were down 11% as of writing, with Aurora Cannabis stock down 8% and Tilray stock down 6%.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns Canopy Growth Corp. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth (TSX:WEED) Tanks Again: How Low Could the Stock Go?

Canopy Growth just reported weak quarterly results. What's next for this cannabis stock?

Read more »

Pot stocks
Cannabis Stocks

Canopy Growth Stock Falls 13% as Revenue Falls 25% on Lower Sales

Canopy Growth (TSX:WEED)(NASDAQ:CGC) stock beat earnings estimates in Q4 but saw net revenue drop year over year by 25%.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Tilray Will Be the First Cannabis Stock to Bounce Back

Tilray is down 38% year to date, but it's one of the only profitable cannabis companies out there.

Read more »

Pot stocks
Cannabis Stocks

Canopy Growth: What Went Wrong?

Before cannabis was legalized in Canada, this stock was soaring, as was its public profile.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Is Cronos Group (TSX:CRON) a Buy After its 1st-Quarter Performance?

Cronos Group remains a high-risk, high-reward stock, despite its solid first-quarter performance.

Read more »

Cannabis smoke
Cannabis Stocks

Aurora Cannabis Stock Hits 52-Week Low: What Investors Should Know

Aurora Cannabis stock continues to fall, hitting a yearly bottom last week. So what should investors do now?

Read more »

edit Jars of marijuana
Cannabis Stocks

Here’s Why Curaleaf Is a Better Cannabis Stock Compared to Sundial!

Cannabis giant Curaleaf ended 2021 with $1.2 billion in sales, making it one of the largest marijuana companies in the…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

2 Cannabis Stocks Better Than Sundial Growers

Here's why Green Thumb Industries and Cresco Labs are much better long-term bets compared to Sundial Growers.

Read more »